Bibliography for Major Depressive Disorder

Fagiolini A, Kupfer DJ: Is treatment-resistant depression a unique subtype of depression? Biol Psychiatry 2003; 53:640–648

Fava M: Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003; 53:649–659

Fava M, Rankin MA, Wright EC, Alpert JE, Nierenberg AA, Pava J, Rosenbaum JF: Anxiety disorders in major depression. Compr Psychiatry 2000; 41:97–102

Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, Endicott J, Coryell W, Kunovac JL, Mueller TI, Rice JP, Keller MB: Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 2000; 57:375–380

Matthews JD, Fava M: Risk of suicidality in depression with serotonergic antidepressants. Ann Clin Psychiatry 2000; 12:43–50

Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M: Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry 2004; 26:13–17

Simon NM, Smoller JW, Fava M, Sachs G, Racette SR, Perlis R, Sonawalla S, Rosenbaum JF: Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression. J Psychiatr Res 2003; 37:187–192

Yeung A, Chang D, Gresham RL Jr, Nierenberg AA, Fava M: Illness beliefs of depressed Chinese American patients in primary care. J Nerv Ment Dis 2004; 192:324–327

American Psychiatric Association: Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors. Arlington, Va, American Psychiatric Association, 2003. Available at http://www.psych.org/psych_pract/treatg/pg/Practice%20Guidelines8904/SuicidalBehaviors.pdf

American Psychiatric Association: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd ed. Washington, DC, American Psychiatric Association, 2000. Available at http://www.psych.org/psych_pract/treatg/pg/Practice%20Guidelines8904/MajorDepressiveDisorder_2e.pdf

Bettinger TL, Crismon ML, Trivedi MH, Grannemann B, Shon SP: Clinicians’ adherence to an algorithm for pharmacotherapy of depression in the Texas public mental health sector. Psychiatr Serv 2004; 55:703–705

Cassano P, Fava M: Tolerability issues during long-term treatment with antidepressants. Ann Clin Psychiatry 2004; 16:15–25

Dunner DL: Duration of periods of euthymia in patients with dysthymic disorder. Am J Psychiatry 1999;156:1992–1993

Fava M, Schmidt ME, Zhang S, Gonzales J, Raute NJ, Judge R: Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatment. Psychother Psychosom 2002; 71:195–199

Garfield P, Kent A, Paykel ES, Creighton FJ, Jacobson RR: Outcome of postpartum disorders: a 10-year follow-up of hospital admissions. Acta Psychiatr Scand 2004; 109:434–439

Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM: Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361(9358):653–661

Gelenberg AJ, Shelton RC, Crits-Christoph P, Keller MB, Dunner DL, Hirschfeld RM, Thase ME, Russell JM, Lydiard RB, Gallop RJ, Todd L, Hellerstein DJ, Goodnick PJ, Keitner GI, Stahl SM, Halbreich U, Hopkins HS: The effectiveness of St. John’s wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication. J Clin Psychiatry 2004; 65:1114–1119

George MS, Wassermann EM, Kimbrell TA, Little JT, Williams WE, Danielson AL, Greenberg BD, Hallett M, Post RM: Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry 1997; 154:1752–1756

Husain MM, Rush AJ, Fink M, Knapp R, Petrides G, Rummans T, Biggs MM, O’Connor K, Rasmussen K, Litle M, Zhao W, Bernstein HJ, Smith G, Mueller M, McClintock SM, Bailine SH, Kellner CH: Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): A Consortium for Research in ECT (CORE) report. J Clin Psychiatry 2004; 65:485–491

Iosifescu DV, Nierenberg AA, Alpert JE, Papakostas GI, Perlis RH, Sonawalla S, Fava M: Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment. Psychosomatics 2004; 45:419–425

Jick H, Kaye JA, and Jick SS: Antidepressants and the risk of suicidal behaviors. JAMA 2004; 292:338–343

Jindal RD, Thase ME: Treatment of insomnia associated with clinical depression. Sleep Med Rev 2004; 8:19–30

Judd LL, Paulus MJ, Schettler PJ, Akiskal HS, Endicott J, Leon AC, Maser JD, Mueller T, Solomon DA, Keller MB: Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000; 157:1501–1504

Katon W, Russo J, Frank E, Barrett J, Williams JW Jr, Oxman T, Sullivan M, Cornell J: Predictors of nonresponse to treatment in primary care patients with dysthymia. Gen Hosp Psychiatry 2002; 24:20–27

Keller MB, Mccullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J, Blalock JA, Borian FE, Jody DN, Debattista C, Koran LM, Schatzberg AF, Fawcett J, Hirschfeld RMA, Keitner G, Miller I, Kocsis JH, Kornstein SG, Manber R, Ninan PT, Rothbaum B, Rush AJ, Vivian D, Rothbaum B: A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000; 342:1462–1470

Kennedy N, Abbott R, Paykel ES: Longitudinal syndromal and sub-syndromal symptoms after severe depression: 10-year follow-up study. Br J Psychiatry 2004; 184:330–336

Kennedy N, Paykel ES: Residual symptoms at remission from depression: impact on long-term outcome. J Affect Disord 2004; 80:135–144

Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, Mccullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB: Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000; 157:1445–1452

March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team: Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 2004; 292:807–820

Moller HJ, Demyttenaere K, Sacchetti E, Rush AJ, Montgomery SA: Improving the chance of recovery from the short- and long-term consequences of depression. Int Clin Psychopharmacol 2003; 18:219–225

Montgomery SA, Baldwin DS, Riley A: Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord 2002; 69:119–140

Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH: Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001; 344:961–966

Nierenberg AA: Predictors of response to antidepressants: general principles and clinical implications. Psychiatr Clin North Am 2003; 26:345–352

Reynolds CF, Frank E, Perel JM, Imber SD, Cornes C, Miller MD, Mazumdar S, Houck PR, Dew MA, Stack JA, Pollock BG, Kupfer DJ: Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 1999; 281:39–45

Rothschild AJ: Challenges in the treatment of depression with psychotic features. Biol Psychiatry 2003; 53:680–690

Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores-Wilson K, Lebowitz BD, Ritz L, Niederehe G; STAR*D Investigators Group. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Control Clin Trials 2004; 25:119–142

Rush AJ, Trevedi M, Carmody TJ, Biggs MM, Shores-Wilson K, Ibrahim H, Crismon ML: One year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies. Biological Psychiatry 2004; 56:46–53

Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z, Johnson CR, Seidman S, Giller C, Haines S, Simpson RK Jr, Goodman RR: Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001; 25:713–728

Segal ZV, Pearson JL, Thase ME: Challenges in preventing relapse in major depression. Report of a National Institute of Mental Health Workshop on state of the science of relapse prevention in major depression. J Affect Disord 2003; 77:97–108

Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, Coryell W, Warshaw M, Turvey C, Maser JD, Endicott J: Multiple recurrences of major depressive disorder. Am J Psychiatry 2000; 157:229–233

Thase ME: Comparing the methods used to compare antidepressants. Psychopharmacol Bull 2002; 36(suppl 1):1–17

Belanoff JK, Kalehzan M, Sund B, Fleming Ficek SK, Schatzberg AF: Cortisol activity and cognitive changes in psychotic major depression. Am J Psychiatry 2001;158:1612–1616

Drevets WC: Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001; 11:240–249

Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Ryan CE, Hess AL, Harrison W, Davis SM, Keller MB: Gender differences in chronic major and double depression. J Affect Disord 2000; 60:1–11

Lin KM: Biological differences in depression and anxiety across races and ethnic groups. J Clin Psychiarty 2001; 62(suppl 13):13–19

Manji HK, Drevets WC, Charney DS: The cellular neurobiology of depression. Nature Med 2001; 7:541–547

Meyer SE, Chrousos GP, Gold PW: Major depression and the stress system: a life span perspective. Dev Psychopathol 2001; 13:565–580

Paykel ES: Stress and affective disorders in humans. Semin Clin Neuropsychiatry 2001; 6:4–11

Sapolsky RM: The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 2000; 48:755–756